Final and Interim Clinical Study Reporting

This contract involves the authorship and delivery of both interim and final clinical study reports, encompassing the preparation of responses to FDA comments, revisions of reports, and the creation of manuscripts suitable for submission to PubMed Central. The work is subcontracted under the NAICS code 541611, which pertains to administrative management and general management consulting services. The contracting agency is the Food and Drug Administration (FDA) Office of Acquisition and Grant Services, part of the Department of Health and Human Services. The contract activities are to be performed in Silver Spring, with a specific focus on timely and accurate documentation that meets regulatory standards. The solicitation was posted on June 8, 2026, with a response deadline set for July 6, 2026, indicating a relatively short window for proposal submission. The contractor will be expected to deliver high-quality clinical study reporting products that support FDA regulatory review processes, ensuring compliance with submission requirements and facilitating publication in recognized scientific repositories.